An Exploratory Study of Combination Therapy With VRC-HIVMAB060-00-AB (VRC01) and 10-1074 in HIVInfected Individuals Undergoing Sequential Treatment Interruptions
Latest Information Update: 14 Oct 2021
At a glance
- Drugs VRC 01 (Primary) ; Zinlirvimab (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
Most Recent Events
- 22 Sep 2021 Status changed from completed to discontinued.
- 09 Dec 2020 Status changed from recruiting to completed.
- 13 Apr 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Apr 2019 to 19 Apr 2019.